Publication date: Mar 19, 2025
In this open-label trial, the overall aim is to determine if TMS treatment can improve anxiety and depression in a broad group of children and youth referred by physicians.
| Concepts | Keywords |
|---|---|
| Calgary | Anxiety |
| Eating | Brain |
| Months | Depression |
| Neurodevelopmental | Disorders |
| Pharmacotherapy | Medication |
| Mental | |
| Onset | |
| Population | |
| Related | |
| Stand | |
| Stimulation | |
| Tms | |
| Treatment | |
| Years | |
| Youth |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | ANxiety |
| disease | MESH | Depression |
| drug | DRUGBANK | Tilmicosin |
| disease | MESH | status epilepticus |
| disease | MESH | suicide attempt |
| disease | MESH | contraindications |
Original Article
(Visited 1 times, 1 visits today)